CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...